Skip to content
10-Q

Quarterly Report

BIOADAPTIVES, INC. BDPT

0001640334-25-000834

← back to feed
Filed
May 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 2, 2025 9.05M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $1.68M
Current Liabilities Q1 2025 · Dec 31, 2024 $1.73M
Total Liabilities Q1 2025 · Mar 31, 2025 $1.68M
Total Liabilities Q1 2025 · Dec 31, 2024 $1.73M
Current Assets Q1 2025 · Mar 31, 2025 $110.45K
Current Assets Q1 2025 · Dec 31, 2024 $261.89K
Total Assets Q1 2025 · Mar 31, 2025 $110.45K
Total Assets Q1 2025 · Dec 31, 2024 $261.89K
Shares Diluted Q1 2025 · Mar 31, 2024 7.7M sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$41.18K
Stockholders Equity Q1 2025 · Mar 31, 2024 −$1.8M
Stockholders Equity Q1 2025 · Dec 31, 2023 −$1.65M
Eps Diluted Q1 2025 · Mar 31, 2024 −$0.04
Sga Expense Q1 2025 · Mar 31, 2024 $31.67K
Net Income Q1 2025 · Mar 31, 2024 −$306.71K
Operating Income Q1 2025 · Mar 31, 2024 −$49.83K
Gross Profit Q1 2025 · Mar 31, 2024 $3.6K
Cost Of Revenue Q1 2025 · Mar 31, 2024 $8.39K
Revenue Q1 2025 · Mar 31, 2024 $11.99K